ECTRIN Erdosteine 300mg Capsule 1's
RXDRUG-DR-XY29596-1pc
Discreet Packaging
FDA-registered Products
FDA-licensed Pharmacies
Indications/Uses
Treatment of acute bronchitis, chronic bronchitis and its exacerbations. Respiratory disorders characterized by abnormal bronchial secretions and impaired mucus transport.
Dosage/Direction for Use
Capsule: 1 cap 2-3 times daily.
Suspension: Adults and Children >30 kg: 10 mL (2 tsp) twice daily.
Children 20-30 kg: 5 mL (1 tsp) 3 times a day; 15-19 kg: 5 mL (1 tsp) twice daily.
Direction for Reconstitution: To make 60 mL suspension: Add 42 mL of water and shake well until all the powder are evenly suspended.
To make 100 mL suspension: Add 70 mL of water and shake well until all the powder are evenly suspended.
Suspension: Adults and Children >30 kg: 10 mL (2 tsp) twice daily.
Children 20-30 kg: 5 mL (1 tsp) 3 times a day; 15-19 kg: 5 mL (1 tsp) twice daily.
Direction for Reconstitution: To make 60 mL suspension: Add 42 mL of water and shake well until all the powder are evenly suspended.
To make 100 mL suspension: Add 70 mL of water and shake well until all the powder are evenly suspended.
Overdosage
With dosages exceeding the recommended dose (1200 mg/day), sweating, vertigo and flushing have been observed.
Administration
May be taken with or without food.
Contraindications
Known hypersensitivity to erdosteine. Because of a possible interference of erdosteine metabolites with the methionine metabolism, erdosteine is contraindicated in patients suffering from hepatic cirrhosis and deficiency of the cystathionine-synthetase enzyme.
Suspension: Phenylketonuria, due to the presence of aspartame.
Suspension: Phenylketonuria, due to the presence of aspartame.
Special Precautions
Effects on the Ability to Drive or Operate Machinery: No effects have been reported.
Use in pregnancy & lactation: The safety of erdosteine during human pregnancy has not been established and therefore, as with all other new drugs, its use is not recommended. Ectrin is also not recommended during lactation.
Use in pregnancy & lactation: The safety of erdosteine during human pregnancy has not been established and therefore, as with all other new drugs, its use is not recommended. Ectrin is also not recommended during lactation.
Use In Pregnancy & Lactation
The safety of erdosteine during human pregnancy has not been established and therefore, as with all other new drugs, its use is not recommended. Ectrin is also not recommended during lactation.
Storage
Store at a temperature not exceeding 30°C. Protect from light.
The reconstituted suspension is stable for 1 week (7 days) at temperatures not exceeding 30°C (room temperature) and 2 weeks (14 days) at 2-8°C temperature (refrigerated).
The reconstituted suspension is stable for 1 week (7 days) at temperatures not exceeding 30°C (room temperature) and 2 weeks (14 days) at 2-8°C temperature (refrigerated).
Action
Pharmacokinetics: Peak plasma levels are reached after 30-60 min. Ectrin has subsequent complete metabolism in similar metabolites.
MedsGo Class
Cough & Cold Preparations
Features
Brand
Ectrin
Full Details
Dosage Strength
300mg
Drug Ingredients
- Erdosteine
Drug Packaging
Capsule 1's
Generic Name
Erdosteine
Dosage Form
Capsule
Registration Number
DR-XY29596
Drug Classification
Prescription Drug (RX)
Please sign in so that we can notify you about a reply